Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcadia Biosciences (RKDA) Revenue (2016 - 2025)

Arcadia Biosciences' Revenue history spans 12 years, with the latest figure at $901000.0 for Q4 2025.

  • For Q4 2025, Revenue fell 25.9% year-over-year to $901000.0; the TTM value through Dec 2025 reached $4.9 million, down 3.73%, while the annual FY2025 figure was $4.9 million, 3.71% down from the prior year.
  • Revenue reached $901000.0 in Q4 2025 per RKDA's latest filing, down from $1.3 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $837.0 million in Q2 2021 to a low of -$5.8 million in Q4 2022.
  • Average Revenue over 5 years is $43.1 million, with a median of $1.3 million recorded in 2023.
  • Peak YoY movement for Revenue: soared 297764.77% in 2021, then tumbled 235.16% in 2022.
  • A 5-year view of Revenue shows it stood at $4.3 million in 2021, then crashed by 235.16% to -$5.8 million in 2022, then soared by 113.37% to $777000.0 in 2023, then soared by 56.5% to $1.2 million in 2024, then dropped by 25.9% to $901000.0 in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Revenue are $901000.0 (Q4 2025), $1.3 million (Q3 2025), and $1.5 million (Q2 2025).